BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22891824)

  • 1. Endovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosis.
    Werner M; Scheinert D; Henn M; Scheinert S; Bräunlich S; Bausback Y; Friedenberger J; Schuster J; Hertting K; Piorkowski M; Rosner C; Schmidt A; Ulrich M; Gutberlet M
    J Endovasc Ther; 2012 Aug; 19(4):467-75. PubMed ID: 22891824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
    Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
    J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease.
    Pulli R; Dorigo W; Pratesi G; Fargion A; Angiletta D; Pratesi C
    J Vasc Surg; 2012 Jan; 55(1):105-12. PubMed ID: 21944917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
    Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
    J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
    Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
    J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force.
    Goltz JP; Ritter CO; Kellersmann R; Klein D; Hahn D; Kickuth R
    J Endovasc Ther; 2012 Jun; 19(3):450-6. PubMed ID: 22788900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outback catheter for femoropopliteal occlusions: immediate and long-term results.
    Bausback Y; Botsios S; Flux J; Werner M; Schuster J; Aithal J; Varcoe R; Bräunlich S; Ulrich M; Scheinert D; Schmidt A
    J Endovasc Ther; 2011 Feb; 18(1):13-21. PubMed ID: 21314343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
    Bosiers M; Deloose K; Callaert J; Moreels N; Keirse K; Verbist J; Peeters P
    J Vasc Surg; 2011 Oct; 54(4):1042-50. PubMed ID: 21636239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of the TIGRIS Vascular Stent Within a Modern Treatment Algorithm.
    Werner M; Gomari-Grisar F; Belalcazar S; Hirschl M; Kalchhauser G; Al-Taiee B; Jäger N; Westhausser C; Tischler M; Tischler R
    J Endovasc Ther; 2019 Oct; 26(5):637-642. PubMed ID: 31303096
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.
    Salapura V; Blinc A; Kozak M; Jezovnik MK; Pohar Perme M; Berden P; Kuhelj D; Kljucevsek T; Popovic P; Stankovic M; Vrtovec M; Surlan M
    Vasa; 2010 May; 39(2):159-68. PubMed ID: 20464672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result.
    Hu H; Zhang H; He Y; Jin W; Tian L; Chen X; Li M
    Ann Vasc Surg; 2011 Feb; 25(2):210-6. PubMed ID: 21315233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
    Owens CD; Gasper WJ; Walker JP; Alley HF; Conte MS; Grenon SM
    J Vasc Surg; 2014 Apr; 59(4):1016-24. PubMed ID: 24423476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia.
    Lichtenberg M; Stahlhoff W; Boese D
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):433-9. PubMed ID: 24013531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.